← SynDRA
NORFLUOXETINE
SynDRA canonical compound SYN0007921 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HTR2B |
|---|
| Mechanism of action | selective serotonin reuptake inhibitor (SSRI) |
|---|
All known targets
- HTR2B
- HTR2A
- HTR2C
- KCNC1
- KCNK2
Mechanisms of action (all sources)
- HTR2B ANTAGONIST
- KCNK2 MODULATOR
- selective serotonin reuptake inhibitor (SSRI)
- HTR2A ANTAGONIST
- HTR2C ANTAGONIST
- KCNC1 INHIBITOR (GATING INHIBITOR)
Cross-references
Synonyms
- Desmethylfluoxetine
- Norfluoxetin
- 3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
- WIQRCHMSJFFONW-UHFFFAOYSA-N
- gamma-(4-(Trifluoromethyl)phenoxy)benzenepropanamine
- norfluoxetine hcl
- 3-Phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine
- 3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine
- Benzenepropanamine, gamma-(4-(trifluoromethyl)phenoxy)-
- benzenepropanamine, gamma-[4-(trifluoromethyl)phenoxy]-
- ( inverted exclamation markA)-
- K8D70XE2F4
- RefChem:166615
- DTXCID50199978
- C16H16F3NO
- (S)-3-PHENYL-3-(4-TRIFLUOROMETHYL-PHENOXY)-PROPYLAMINE
- (R)-3-Phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine
- UNII-K8D70XE2F4
- (R)-Norfluoxetine-d5 (Phenyl-d5)
- Benzenepropanamine, g-[4-(trifluoromethyl)phenoxy]-
- GTPL208
- SCHEMBL686500
- orb2564269
- CHEBI:180876
- (+/-)-DESMETHYLFLUOXETINE
- SYB64864
- BDBM50180661
- MFCD00865401
- NSC675448
- AKOS015911091
- NSC-675448
- SB32578
- SB32682
- SB38941
- DB-262477
- HY-135556
- CS-0113461
Look up NORFLUOXETINE in the interactive SynDRA portal →